354 related articles for article (PubMed ID: 15530887)
1. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
[TBL] [Abstract][Full Text] [Related]
2. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
3. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
Yun W; Hua-bing W; Wei-zhi W
J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
[TBL] [Abstract][Full Text] [Related]
4. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens.
Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J
J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331
[TBL] [Abstract][Full Text] [Related]
5. The effects of monoamine reuptake inhibiting antidepressants in experimental allergic neuritis.
Zhu J; Mix E; Bengtsson BO; Link H
J Peripher Nerv Syst; 1997; 2(1):30-42. PubMed ID: 10975734
[TBL] [Abstract][Full Text] [Related]
6. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
[TBL] [Abstract][Full Text] [Related]
8. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
De La Hoz CL; Castro FR; Santos LM; Langone F
Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
[TBL] [Abstract][Full Text] [Related]
9. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin.
Zhu J; Bai XF; Mix E; Link H
Clin Immunol Immunopathol; 1997 Jul; 84(1):85-94. PubMed ID: 9191887
[TBL] [Abstract][Full Text] [Related]
10. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
Duan RS; Chen Z; Bao L; Quezada HC; Nennesmo I; Winblad B; Zhu J
Neurobiol Dis; 2004 Aug; 16(3):630-7. PubMed ID: 15262275
[TBL] [Abstract][Full Text] [Related]
11. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
Zhang Z; Zhang ZY; Schluesener HJ
J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
[TBL] [Abstract][Full Text] [Related]
13. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuroscience; 2010 Aug; 169(1):370-7. PubMed ID: 20451583
[TBL] [Abstract][Full Text] [Related]
14. Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
Tan XD; Dou YC; Shi CW; Duan RS; Sun RP
J Neuroimmunol; 2009 Feb; 207(1-2):39-44. PubMed ID: 19174309
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Zhu J
J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976
[TBL] [Abstract][Full Text] [Related]
16. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response.
Zhang HL; Azimullah S; Zheng XY; Wang XK; Amir N; Mensah-Brown EP; Al Shamsi M; Shahin A; Press R; Zhu J; Adem A
J Neuroimmunol; 2012 May; 246(1-2):18-26. PubMed ID: 22445739
[TBL] [Abstract][Full Text] [Related]
18. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
[TBL] [Abstract][Full Text] [Related]
19. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis.
Deng YN; Zhou WB
Neuroimmunomodulation; 2007; 14(6):337-43. PubMed ID: 18434754
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
Kiefer R; Gold R; Gehrmann J; Lindholm D; Wekerle H; Kreutzberg GW
J Neurosci Res; 1993 Nov; 36(4):391-8. PubMed ID: 7505838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
